These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25735983)

  • 1. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
    Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
    Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
    Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
    Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
    Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
    Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines.
    Junk S; Cario G; Wittner N; Stanulla M; Scherer R; Schlegelberger B; Schrappe M; von Neuhoff N; Lauten M
    Klin Padiatr; 2015 May; 227(3):123-30. PubMed ID: 25985447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
    Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
    Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
    Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
    Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil.
    Harris DR; Mims A; Bunz F
    Cancer Biol Ther; 2012 Nov; 13(13):1319-24. PubMed ID: 22895071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
    Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
    J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
    Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
    Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.
    Bianchetti E; Bates SJ; Carroll SL; Siegelin MD; Roth KA
    Sci Rep; 2018 Nov; 8(1):17390. PubMed ID: 30478285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
    Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
    Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.
    Sarvaiya PJ; Schwartz JR; Hernandez CP; Rodriguez PC; Vedeckis WV
    Am J Hematol; 2012 Oct; 87(10):969-76. PubMed ID: 22764095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Bhadri VA; Cowley MJ; Kaplan W; Trahair TN; Lock RB
    BMC Genomics; 2011 Nov; 12():565. PubMed ID: 22093874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.
    Shi PJ; Xu LH; Lin KY; Weng WJ; Fang JP
    J Hematol Oncol; 2016 Feb; 9():12. PubMed ID: 26892465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies.
    Yang A; Ma J; Wu M; Qin W; Zhao B; Shi Y; Jin Y; Xie Y
    Leuk Lymphoma; 2012 Dec; 53(12):2465-73. PubMed ID: 22582938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia.
    Sarno J; Domizi P; Liu Y; Merchant M; Pedersen CB; Jedoui D; Jager A; Nolan GP; Gaipa G; Bendall SC; Bava FA; Davis KL
    Nat Commun; 2023 May; 14(1):2935. PubMed ID: 37217509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
    Han SS; Han S; Kamberos NL
    Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinase USP9X stabilizes RNA m
    Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H
    J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice.
    Uckun FM; Myers DE; Cheng J; Qazi S
    EBioMedicine; 2015 Jun; 2(6):554-62. PubMed ID: 26285772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
    Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
    Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.